Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-05-21
1994-03-01
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514245, 544207, 544209, 544212, 544217, 544219, C07D40514, A51K 3153
Patent
active
052907767
ABSTRACT:
A compound of the formula I ##STR1## wherein: R.sup.1 is hydrogen, (1-6C)alkyl, or (1-4C)alkanoyl;
REFERENCES:
patent: 3846423 (1974-11-01), Kobe et al.
patent: 3995039 (1976-11-01), Rooney et al.
patent: 4133674 (1979-01-01), Cartwright et al.
patent: 4560689 (1985-12-01), Yokoyama
patent: 4713383 (1987-12-01), Francis et al.
patent: 4734413 (1988-03-01), Wade
W. Ried, S. Aboul-Fetouh "Synthesis of new Substituted Pyrazolo[1,4-a]pyrimidines and Pyrazolo[1,5-a]-1,3,5-Triazines" Tetrahedron (1988), 44, 7155-7162.
J. P. Miller, et al. "Inhibition of Cyclic AMP Phosphodiesterases by Cyclic Nucleotide Analogs and Nitrogen Heterocycles" Advances in Cyclic Nucleotide and Protein Phosphorylation Research (1984), 16, 277-290.
K. Senga, et al. "Synthesis and Enzymic Acitivity of Various Substituted Pyrazolo-[1,5-a]-1,3,5-triazines as Adensoine Cyclic 3',5'-Phosphate Phosphodiesterase Inhibitors"J. Med Chem (1982), 25, 243-249.
G. Griebel, et al. "Behavioural effects of Selective A.sub.2 Adenosine Receptor Antagonists, CGS 21197 and CGS 22706, in Mice" NeuroReport (1991), 2, 139-140.
S. P. Langdon, et al. "Triazines and Related Products. Part 26. Synthesis and Chemistry of Bicyclic Analogs of Antiiumor Drug 2,4,6-Tris(dimethylamino)-1,3,5-triazine (Hexamethylmelamine)" J. Chem. SOC., Perkin Trans I (1984), 993-998.
Callis, et al. "Inhibition of Renal Vasoconstriction Induced by Intrarenal Hypertonic Sailne by the Nonxanthine Adenosine Antagonist CGS 1594A" J. Pharmacol Exp. Therap (1989), 248 (3), 1123-1129.
E. B. Akerblom, D. E. S. Campbell "Nitrofuryltriazole Derivatives as Potential Urinary Tract Antibacterial Agents" J. Med. Chem. (1973), 16(4) 312-319.
Caulkett Peter W. R.
Collis Michael G.
Jones Geraint
Poucher Simon M.
Ford John M.
Imperial Chemical Industries PLC
LandOfFree
Azole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-577243